Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Effectiveness of Action-based Cognitive Remediation for First Episode Psychosis

NCT03814122 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT03814122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03814122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Effectiveness of Action-based Cognitive Remediation for First Episode Psychosis
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Completed
Start date
February 13, 2019
Completion date
November 30, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, psychosis